ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Mestag Therapeutics Ltd

Mestag Therapeutics Ltd is an active company incorporated on 17 February 2020 with the registered office located in Saffron Walden, Essex. Mestag Therapeutics Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12466144
Private limited company
Age
5 years
Incorporated 17 February 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Confirmation
Submitted
Dated 15 February 2025 (8 months ago)
Next confirmation dated 15 February 2026
Due by 1 March 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
Suites 15 & 16, Science Village Chesterford Research Park
Little Chesterford
Saffron Walden
CB10 1XL
England
Same address for the past 4 years
Telephone
07818 430877
Email
Unreported
Website
Unreported
People
Officers
10
Shareholders
35
Controllers (PSC)
1
Director • British • Lives in England • Born in Apr 1960
Director • Dutch • Lives in Netherlands • Born in Jul 1958
Director • Canadian • Lives in Netherlands • Born in Sep 1990
Director • British • Lives in England • Born in Mar 1974
Director • American • Lives in United States • Born in Apr 1967
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham and Dr Andrew Neil Charles Weir are mutual people.
Active
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Quell Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Nucleome Therapeutics Limited
Dr Fiona Caroline Maclaughlin is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Brands
Mestag Therapeutics
Mestag Therapeutics is an immunology company focused on developing treatments for cancer and inflammatory diseases.
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£23.58M
Increased by £14.03M (+147%)
Turnover
Unreported
Same as previous period
Employees
42
Increased by 9 (+27%)
Total Assets
£29.32M
Increased by £15.79M (+117%)
Total Liabilities
-£60.98M
Increased by £31.85M (+109%)
Net Assets
-£31.66M
Decreased by £16.07M (+103%)
Debt Ratio (%)
208%
Decreased by 7.18% (-3%)
Latest Activity
Martinus Adrianus Van Osch Appointed
5 Months Ago on 2 Jun 2025
Antoine Boulanger Piette Resigned
5 Months Ago on 2 Jun 2025
Own Shares Purchased
5 Months Ago on 22 May 2025
Shares Cancelled
5 Months Ago on 22 May 2025
Small Accounts Submitted
6 Months Ago on 8 May 2025
Confirmation Submitted
8 Months Ago on 24 Feb 2025
Small Accounts Submitted
1 Year Ago on 23 Oct 2024
Johnson & Johnson (PSC) Appointed
1 Year Ago on 14 Oct 2024
Juliette Audet Resigned
1 Year 8 Months Ago on 29 Feb 2024
Dr Antoine Boulanger Piette Appointed
1 Year 8 Months Ago on 29 Feb 2024
Get Credit Report
Discover Mestag Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 31 October 2025
Submitted on 3 Nov 2025
Statement of capital following an allotment of shares on 24 September 2025
Submitted on 24 Sep 2025
Termination of appointment of Antoine Boulanger Piette as a director on 2 June 2025
Submitted on 3 Jun 2025
Appointment of Martinus Adrianus Van Osch as a director on 2 June 2025
Submitted on 3 Jun 2025
Purchase of own shares.
Submitted on 22 May 2025
Cancellation of shares. Statement of capital on 2 May 2025
Submitted on 22 May 2025
Change of share class name or designation
Submitted on 22 May 2025
Accounts for a small company made up to 31 December 2024
Submitted on 8 May 2025
Statement of capital following an allotment of shares on 28 April 2025
Submitted on 29 Apr 2025
Confirmation statement made on 15 February 2025 with updates
Submitted on 24 Feb 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year